1-4 of 4
James O. Armitage, M.D
Close
Sort by
Journal Articles

Association of Follow-up Care Characteristics and Outcomes According to Number of Follow-up Providers Among Survivors of Hematologic Malignancies.

Anthony J. Cannon, B.S., Deborah L. Darrington, M.D., Linda K. Bauer, B.S., James O. Armitage, M.D., Julie M. Vose, M.D., Fausto R. Loberiza, Jr., M.D., M.S.
Journal: Blood
Blood (2009) 114 (22): 1375.
https://doi.org/10.1182/blood.V114.22.1375.1375
Published: 2009
Journal Articles

Bendamustine, Bortezomib and Rituximab in Patients (pts) Relapsed/Refractory Indolent and Mantle Cell Non-Hodgkin Lymphoma (NHL): a Multicenter Phase II Clinical Trial.

Jonathan W. Friedberg, MD, Julie M. Vose, M.D., Jennifer L Kelly, PhDMPH, Faith Young, MD, Jane Liesveld, MD, James O. Armitage, M.D., Nicole Proia, MPH, Kim Cruttenden, N.P., John P. Leonard, MD
Journal: Blood
Blood (2009) 114 (22): 924.
https://doi.org/10.1182/blood.V114.22.924.924
Published: 2009
Journal Articles

Prognostic Significance of Circulating Lymphoma Cells in Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL).

Disni Muringampurath-John, MBBS, Christopher R. Flowers, MD, Adnan A Jabbar, MD, PhD, Rajni Sinha, MD, MRCP, Martha Arellano, MD, Leon Bernal-Mizrachi, MD, Jonathan L. Kaufman, MD, David L. Jaye, MD, Zhengjia Chen, Mary Jo Lechowicz, MD, Sagar Lonial, MD, James O. Armitage, M.D., H. Jean Khoury, MD
Journal: Blood
Blood (2009) 114 (22): 2947.
https://doi.org/10.1182/blood.V114.22.2947.2947
Published: 2009
Journal Articles

FDG-PET in Peripheral T-Cell Lymphoma.

Joanna M. Quigley, BA, Shrinivas Bishu, M.D., Jordan H. Hankins, M.D., James O. Armitage, M.D
Journal: Blood
Blood (2006) 108 (11): 5499.
https://doi.org/10.1182/blood.V108.11.5499.5499
Published: 2006